Naglazyme® (galsulfase)
| Full Name | Naglazyme® (galsulfase) |
| Drug | Naglazyme |
| Manufacturer | BioMarin Pharmaceutical Inc. |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Patients with Mucopolysaccharidosis VI (MPS VI; Maroteaux-Lamy Syndrome) |
| Disease | Mucopolysaccharidosis VI |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Naglazyme Enrollment Form |
| Phone Number | 800-240-9572 |
| Fax Number | 877-220-7581 |
| Product Website | naglazyme.com |